Page last updated: 2024-10-26

disopyramide and Ductus Arteriosus, Patent

disopyramide has been researched along with Ductus Arteriosus, Patent in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, WJ1
Tyrrell, MJ1
Bharadwaj, BB1

Other Studies

1 other study available for disopyramide and Ductus Arteriosus, Patent

ArticleYear
Disopyramide as a negative inotrope in obstructive cardiomyopathy in children.
    The Canadian journal of cardiology, 1991, Volume: 7, Issue:2

    Topics: Cardiomyopathy, Hypertrophic; Carnitine; Child; Disopyramide; Ductus Arteriosus, Patent; Echocardiog

1991